Kyle Moritzkat, based in Philadelphia, PA, US, is currently a Director, Analytical CMC at GEMMA Biotherapeutics. Kyle Moritzkat brings experience from previous roles at GEMMA Biotherapeutics, Gene Therapy Program | University of Pennsylvania and MTF Biologics. Kyle Moritzkat holds a 2024 - 2026 Master of Regulatory Affairs in Regulatory Affairs @ University of Pennsylvania. Kyle Moritzkat has 3 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Kyle Moritzkat?
Find contact details for 700 million professionals.